Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days within which to revise and extend their remarks and include extraneous materials on H.R. 2851. The SPEAKER pro tempore (Mr. Fitzpatrick). Is there objection…

Mr. Chairman, how much time is remaining on my side? The CHAIR. The gentleman from Pennsylvania has 16 minutes remaining.

Mr. Chairman, I yield 3 minutes to the gentleman from Oregon (Mr. Walden), who chairs the Energy and Commerce Committee.

Mr. Chairman, this amendment requires the Drug Enforcement Administration to compile a report on both the lawful and illicit sale of synthetic drug analogues over the internet. Unfortunately, the internet and the dark web have become…

Mr. Chairman, I claim the time in opposition to the amendment, although I am not opposed to the amendment. The Acting CHAIR. Without objection, the gentleman from Pennsylvania is recognized for 5 minutes. There was no objection.

Mr. Chair, section 9 of the bill would provide guidance in sentencing during the current problematic time for courts, prosecutors, and defendants. Courts are having difficulties similar to those of law enforcement because of the constantly…

Mr. Chairman, this amendment makes three impactful changes to SITSA. First, it changes and sets strict definitions of what constitutes a controlled substance analogue suitable for inclusion in schedule A. A substance proposed for inclusion…

Mr. Chairman, I thank the gentleman for yielding. Mr. Chairman, this amendment would improve the Federal Analogue Act, a provision in the Controlled Substance Act, which, during a prosecution, allows a chemical that is determined to be…

Mr. Speaker, I rise today in honor of World Blood Donor Day and to celebrate and thank the 7 million Americans who choose to donate blood each year. Generosity saved the life of my dear friend and roommate, Congressman Steve Scalise, after…

Mr. Chairman, I thank the gentlewoman for yielding the time. Mr. Chairman, synthetic opioids are a dangerous new frontline in our efforts to end the opioid epidemic ravaging our communities. A recent analysis found that synthetic opioids…

Mr. Speaker, normally at this time the majority leader and I do a colloquy. We do a colloquy to discuss the schedule for the week to come. My suspicion is they don't know what the schedule is for the week to come because they were going to…

Mr. Speaker, in America, 91 people die every day from an opioid overdose. According to the Washington State Department of Health, from 2012 to 2016, almost 300 people in my Fourth Congressional District died from an opioid-related death…

Mr. Speaker, I rise today to recognize Hank Leo and Amanda Larson, members of the Oneida Rotary Club. Hank and Amanda both recently received the Roses to the Living Award at the Kallet Civic Center. This award is given to Rotarians who…

Mr. Speaker, unfortunately, due to a funeral, I will miss the vote on H.R. 2851, Stop Importation and Trafficking of Synthetic Analogues Act of 2017. It was my intention to vote ``no.'' PERSONAL EXPLANATION

Mr. Chair, I yield myself such time as I may consume. Mr. Chairman, I rise today in support of my manager's amendment to the legislation at issue today, H.R. 5735, the THRIVE Act, which, again, would make supportive housing more accessible…

Mr. Chairman, in conclusion, I accept and support the gentlewoman's amendment. I will just remind all Members, and especially Members who might be considering whether or not they want to vote for the legislation, if you are concerned about…

Mr. Chairman, I rise today in support of my legislation, H.R. 5735, the Transitional Housing for Recovery in Viable Environments Act, or the THRIVE Act. I thank Chairman Hensarling, Chairman Duffy, and my colleagues on the House Financial…

Mr. Chairman, HUD Secretary Ben Carson visited several of these transitional nonprofits in my district in Kentucky earlier this year, and he witnessed firsthand the success of these evidence-based models of recovery. I would like to…